Top Ten Equity Holdings and Exposures

Summary by AI BETAClose X

As of August 29, 2025, Polar Capital Global Healthcare Trust PLC's top ten equity holdings represent 44.3% of its portfolio, with Eli Lilly & Co leading at 6.8% and AstraZeneca following at 6.6%. Sector exposure is heavily weighted towards Pharmaceuticals at 27.2%, Biotechnology at 25.3%, and Healthcare Equipment at 23.6%. The fund's geographic exposure is primarily in the United States at 51.4%, followed by Denmark at 12.8% and the United Kingdom and Netherlands both at 6.6%. Cash holdings account for 1.1% of the portfolio.

Disclaimer*

UK 100

Latest directors dealings